LUPIN
Quarterly Results Analysis [Dec2024]
LUPIN Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹5,768 Cr | ₹5,673 Cr | ₹5,600 Cr | ₹4,961 Cr | ₹5,197 Cr | ₹5,039 Cr | ₹4,814 Cr | ₹4,430 Cr |
Expenses | ₹4,412 Cr | ₹4,332 Cr | ₹4,359 Cr | ₹3,964 Cr | ₹4,159 Cr | ₹4,121 Cr | ₹3,958 Cr | ₹3,852 Cr |
Operating Income | ₹1,356 Cr | ₹1,340 Cr | ₹1,241 Cr | ₹997 Cr | ₹1,038 Cr | ₹918 Cr | ₹856 Cr | ₹578 Cr |
Other Income | ₹54 Cr | ₹42 Cr | ₹68 Cr | ₹29 Cr | ₹29 Cr | ₹40 Cr | ₹23 Cr | ₹37 Cr |
Interest | ₹67 Cr | ₹71 Cr | ₹68 Cr | ₹71 Cr | ₹74 Cr | ₹81 Cr | ₹86 Cr | ₹93 Cr |
Depreciation | ₹271 Cr | ₹257 Cr | ₹248 Cr | ₹457 Cr | ₹257 Cr | ₹248 Cr | ₹235 Cr | ₹264 Cr |
Profit Before Tax | ₹1,071 Cr | ₹1,055 Cr | ₹993 Cr | ₹498 Cr | ₹736 Cr | ₹630 Cr | ₹559 Cr | ₹259 Cr |
Profit After Tax | ₹859 Cr | ₹859 Cr | ₹806 Cr | ₹368 Cr | ₹619 Cr | ₹495 Cr | ₹453 Cr | ₹242 Cr |
EPS | ₹18.74 | ₹18.69 | ₹17.57 | ₹7.89 | ₹13.46 | ₹10.76 | ₹9.94 | ₹5.19 |
Industry Peers & Returns | 1W | 1M | 1Y |
LUPIN | -4.6% | 6.1% | 28% |
SUN PHARMACEUTICAL INDUSTRIES | -3% | 5.6% | 9.3% |
DIVIS LABORATORIES | 1% | 2.7% | 70.3% |
CIPLA | -2.7% | 0.4% | -0.4% |
TORRENT PHARMACEUTICALS | 0.1% | 7.2% | 25.7% |
DR REDDYS LABORATORIES | -3.1% | -0.2% | -6.2% |
MANKIND PHARMA | 2% | 7.1% | 8.8% |
ZYDUS LIFESCIENCES | -3% | 0.1% | -9.3% |
AUROBINDO PHARMA | -2.8% | 5.9% | 13.4% |
LUPIN Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 1.67 % |
Y-o-Y | 10.97 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹5,768 Cr | 1.67 | |
Sep2024 | ₹5,673 Cr | 1.29 | |
Jun2024 | ₹5,600 Cr | 12.89 | |
Mar2024 | ₹4,961 Cr | -4.55 | |
Dec2023 | ₹5,197 Cr | 3.15 | |
Sep2023 | ₹5,039 Cr | 4.66 | |
Jun2023 | ₹4,814 Cr | 8.67 | |
Mar2023 | ₹4,430 Cr | - |
LUPIN Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 1.16 % |
Y-o-Y | 30.63 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹1,356 Cr | 1.16 | |
Sep2024 | ₹1,340 Cr | 8.01 | |
Jun2024 | ₹1,241 Cr | 24.50 | |
Mar2024 | ₹997 Cr | -3.97 | |
Dec2023 | ₹1,038 Cr | 13.09 | |
Sep2023 | ₹918 Cr | 7.18 | |
Jun2023 | ₹856 Cr | 48.21 | |
Mar2023 | ₹578 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -0.51 % |
Y-o-Y | 17.73 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 23.51% | -0.51 | |
Sep2024 | 23.63% | 6.63 | |
Jun2024 | 22.16% | 10.30 | |
Mar2024 | 20.09% | 0.60 | |
Dec2023 | 19.97% | 9.67 | |
Sep2023 | 18.21% | 2.36 | |
Jun2023 | 17.79% | 36.43 | |
Mar2023 | 13.04% | - |
LUPIN Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -0.07 % |
Y-o-Y | 38.82 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹859 Cr | -0.07 | |
Sep2024 | ₹859 Cr | 6.70 | |
Jun2024 | ₹806 Cr | 118.77 | |
Mar2024 | ₹368 Cr | -40.48 | |
Dec2023 | ₹619 Cr | 24.91 | |
Sep2023 | ₹495 Cr | 9.26 | |
Jun2023 | ₹453 Cr | 87.03 | |
Mar2023 | ₹242 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -1.72 % |
Y-o-Y | 25.13 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 14.89 % | -1.72 | |
Sep2024 | 15.15 % | 5.35 | |
Jun2024 | 14.38 % | 93.80 | |
Mar2024 | 7.42 % | -37.65 | |
Dec2023 | 11.9 % | 21.06 | |
Sep2023 | 9.83 % | 4.35 | |
Jun2023 | 9.42 % | 72.21 | |
Mar2023 | 5.47 % | - |
LUPIN Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 0.27 % |
Y-o-Y | 39.23 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹18.74 | 0.27 | |
Sep2024 | ₹18.69 | 6.37 | |
Jun2024 | ₹17.57 | 122.69 | |
Mar2024 | ₹7.89 | -41.38 | |
Dec2023 | ₹13.46 | 25.09 | |
Sep2023 | ₹10.76 | 8.25 | |
Jun2023 | ₹9.94 | 91.52 | |
Mar2023 | ₹5.19 | - |
You may also like the below Video Courses